3,4-Methylenedioxymethamphetamine (Ecstasy) decreases inflammation and airway reactivity in a murine model of asthma

NeuroImmunoModulation

Volumn 19, Issue 4, 2012, Pages 209-219

  Stankevicius, Daniel ^a   Ferraz De Paula, Viviane ^a   Ribeiro, Alison ^a   Pinheiro, Milena Lobão ^a   Ligeiro De Oliveira, Ana P ^a   Damazo, Amílcar S ^b   Lapachinske, Sílvio F ^a   Moreau, Regina L M ^a   Tavares De Lima, Wothan ^a   Palermo Neto, João ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CUIABÁ   (Brazil)

Author keywords

3,4 Methylenedioxymethamphetamine; Airway reactivity; Allergic lung inflammation; Corticosterone; Ecstasy; Leukocyte migration

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; L SELECTIN; METHACHOLINE; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BLOOD; BONE MARROW; CYTOKINE PRODUCTION; DRUG EFFECT; HISTOLOGY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LUNG LAVAGE; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

ANIMALS; ASTHMA; BONE MARROW CELLS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; LUNG; MALE; MAST CELLS; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; TH2 CELLS; TRACHEA;

EID: 84858963905     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000334098     Document Type: Article

References (49)

1. Liechti ME, Gamma A, Vollenweider FX: Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 2001;154:161-168. (Pubitemid 32186501)
2. Logan BJ, Laverty R, Sanderson WD, Yee YB: Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 1988;152:227-234.
3. Zemishlany Z, Aizenberg D, Weizman A: Subjective effects of MDMA ('ecstasy') on human sexual function. Eur Psychiatry 2001;16:127-130. (Pubitemid 32233917)
4. Sterk CE, Klein H, Elifson KW: Young adult ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice. J Psychoactive Drugs 2008;40:237-244.
5. Downing J: The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 1986;18:335-340.
6. Verheyden SL, Henry JA, Curran HV: Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Hum Psychopharmacol 2003;18:507-517. (Pubitemid 37279232)
7. Greene SL, Dargan PI, O'Connor N, Jones AL, Kerins M: Multiple toxicity from 3,4-methylenedioxymethamphetamine ('ecstasy'). Am J Emerg Med 2003;21:121-124.
8. O'Shea E, Granados R, Esteban B, Colado MI, Green AR: The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 1998;37:919-926. (Pubitemid 28375758)
9. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 2003;55:463-508. (Pubitemid 37013213)
10. Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R: Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 2008;107:1102-1112.
11. de Paula VF, Ribeiro A, Pinheiro ML, Sakai M, Lacava MC, Lapachinske SF, Moreau RL, Palermo-Neto J: Methylenedioxymethamphetamine (ecstasy) decreases neutrophil activity and alters leukocyte distribution in bone marrow, spleen and blood. Neuroimmunomodulation 2009;16:191-200.
12. Boyle NT, Connor TJ: Methylenedioxymethamphetamine ('ecstasy')-induced immunosuppression: a cause for concern? Br J Pharmacol 2010;161:17-32.
13. Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Lopez CH, Ortuno J, Segura J, Cami J, de la Torre R: Immunomodulating activity of MDMA. Ann NY Acad Sci 2000;914:215-224.
14. Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R: Effects of repeated doses of MDMA ('ecstasy') on cell-mediated immune response in humans. Life Sci 2001;69:2931-2941. (Pubitemid 33030281)
15. Pacifici R, Zuccaro P, Farre M, Poudevida S, Abanades S, Pichini S, Langohr K, Segura J, de la Torre R: Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans. Addiction 2007;102:931-936. (Pubitemid 46802231)
16. Connor TJ: Methylenedioxymethamphetamine (MDMA, 'ecstasy'): a stressor on the immune system. Immunology 2004;111:357-367.
17. Pennock JW, Stegall R, Bubar MJ, Milligan G, Cunningham KA, Bourne N: 3,4-Methylenedioxymethamphetamine increases susceptibility to genital herpes simplex virus infection in mice. J Infect Dis 2009;200:1247-1250.
18. Connor TJ, Dennedy MC, Harkin A, Kelly JP: Methylenedioxymethamphetamine- induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin. Eur J Pharmacol 2001;418:147-152. (Pubitemid 32378822)
19. Connor TJ, Kelly JP, McGee M, Leonard BE: Methylenedioxymethamphetamine (MDMA;ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sci 2000;67:1601-1612. (Pubitemid 30663016)
20. Connor TJ, Harkin A, Kelly JP: Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10. J Pharmacol Exp Ther 2005;312:134-143. (Pubitemid 40096462)
21. Boyle NT, Connor TJ: MDMA ('ecstasy') suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Eur J Pharmacol 2007;572:228-238. (Pubitemid 47440092)
22. Pacifici R, Zuccaro P, Hernandez Lopez C, Pichini S, Di Carlo S, Farre M, Roset PN, Ortuno J, Segura J, Torre RL: Acute effects of 3,4- methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther 2001;296:207-215. (Pubitemid 32015080)
23. Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset PN, Segura J, de la Torre R: Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans. J Pharmacol Exp Ther 2004;309:285-292. (Pubitemid 38393141)
24. Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Segura J, de la Torre R: Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study. Life Sci 1999;65:PL309-PL316.
25. Kucharewicz I, Bodzenta-Lukaszyk A, Buczko W: Experimental asthma in rats. Pharmacol Rep 2008;60:783-788.
26. Lacava M, Ferraz-de-Paula V, Lapachinske SF, Palermo-Neto J, Moreau RLM: Simultaneous determination of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in plasma by gas chromatography with nitrogen-phosphorus detection (GC-NPD) and in vitro effects on the neutrophil activity of mice. Bogotá, III Encuentro Regional de Toxicologia Forense, TIAFT, 2007, pp 97-104.
27. Ligeiro-Oliveira AP, Fialho de Araujo AM, Lazzarini R, Silva ZL, De Nucci G, Muscara MN, Tavares de Lima W, Palermo-Neto J: Effects of amphetamine on immune-mediated lung inflammatory response in rats. Neuroimmunomodulation 2004;11:181-190.
28. Proust B, Nahori MA, Ruffie C, Lefort J, Vargaftig BB: Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic Balb/c and IL-4ralpha knockout mice. Clin Exp Allergy 2003;33:119-131. (Pubitemid 36114918)
29. Massoco C, Palermo-Neto J: Effects of midazolam on equine innate immune response: a flow cytometric study. Vet Immunol Immunopathol 2003;95:11-19. (Pubitemid 37102758)
30. de Lima WT, da Silva ZL: Contractile responses of proximal and distal trachea segments isolated from rats subjected to immunological stimulation: role of connective tissue mast cells. Gen Pharmacol 1998;30:689-695.
31. van Rossum J, van den Brink F: Cumulative dose-response curves. 1. Introduction to the technique. Arch Int Pharmacodyn Ther 1963;143:240-246.
32. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M: Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010;184:1663-1674.
33. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001;344:350-362. (Pubitemid 32107645)
34. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B: Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998;101:2129-2139. (Pubitemid 28244097)
35. Cotran RS, Mayadas-Norton T: Endothelial adhesion molecules in health and disease. Pathol Biol (Paris) 1998;46:164-170. (Pubitemid 28160660)
36. Lloyd CM, Hessel EM: Functions of T cells in asthma: more than just T(h)2 cells. Nat Rev Immunol 2010;10:838-848.
37. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
38. Rothenberg ME: Eosinophilia. N Engl J Med 1998;338:1592-1600.
39. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev 2010;21:331-344.
40. Maddox L, Schwartz DA: The pathophysiology of asthma. Annu Rev Med 2002;53:477-498. (Pubitemid 34177892)
41. Righi DA, Palermo-Neto J: Behavioral effects of type II pyrethroid cyhalothrin in rats. Toxicol Appl Pharmacol 2003;191:167-176. (Pubitemid 36999852)
42. Righi DA, Palermo-Neto J: Effects of type II pyrethroid cyhalothrin on peritoneal macrophage activity in rats. Toxicology 2005;212:98-106. (Pubitemid 40984023)
43. Righi DA, Xavier FG, Palermo-Neto J: Effects of type II pyrethroid cyhalothrin on rat innate immunity: a flow cytometric study. Int Immunopharmacol 2009;9:148-152.
44. Quinteiro-Filho WM, Righi DA, Palermo-Neto J: Effect of cyhalothrin on Ehrlich tumor growth and macrophage activity in mice. Braz J Med Biol Res 2009;42:912-917.
45. Ligeiro de Oliveira AP, Lazzarini R, Cavriani G, Quinteiro-Filho WM, Tavares de Lima W, Palermo-Neto J: Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats. Int Immunopharmacol 2008;8:1164-1171.
46. de Oliveira AP, Lino-Dos-Santos-Franco A, Hamasato EK, Quinteiro-Filho W, Hebeda CB, Damazo AS, Farsky SH, Tavares-de-Lima W, Palermo-Neto J: Amphetamine modulates cellular recruitment and airway reactivity in a rat model of allergic lung inflammation. Toxicol Lett 2011;200:117-123.
47. Cameron L, Hamid Q: Regulation of allergic airways inflammation by cytokines and glucocorticoids. Curr Allergy Asthma Rep 2001;1:153-163.
48. Liu C, Zhou J, Zhang LD, Wang YX, Kang ZM, Chen YZ, Jiang CL: Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells. Horm Metab Res 2007;39:273-277. (Pubitemid 46715885)
49. Zosky GR, Sly PD: Animal models of asthma. Clin Exp Allergy 2007;37: 973-988. (Pubitemid 46955517)